Biostage, Inc.
Holliston, MA · Medtech · Public
Tissue-engineered esophageal implant combining synthetic scaffold with patient-derived stem cells for long-gap esophageal atresia repair
- Grants
- $2.3M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $22K
- 4 awards · Veterans Affairs, Agriculture, Health and Human S
- #609 of 4531 in medtech
- Patents
- 26
- 14 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Mitocell Respiration System 300-1000 | $6,360 | |
| Federal contract | Department of Agriculture · Igf::ot::igf Phd Ultra 4400 High Pressure Syringe Pump And Stainless Steel Syringe | $6,835 | |
| Federal contract | Department of Health and Human Services · Laboratory Equipment And Supplies | $3,197 | |
| Federal contract | Department of Health and Human Services · Laboratory Equipment And Supplies | $5,963 | |
| Federal grant | Department of Health and Human Services · Phase II · A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia | $224,615 | |
| Federal grant | Department of Health and Human Services · Phase II · A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia | $1,602,095 | |
| Federal grant | Department of Health and Human Services · Phase II · A retrievable autologous bioengineered esophageal implant as a novel treatment for long-gap esophageal atresia | $498,749 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 606 | AVIA BIOSYSTEMS, LLC | $25K | $1.1M |
| 607 | Trice Medical, Inc. | $24K | $90M |
| 608 | Xtant Medical Holdings, Inc. | $24K | $169M |
| 609 | Biostage, Inc. | $22K | — |
| 610 | BLOXR Corp | $20K | $7.1M |
| 611 | Cadence Biomedical, Inc. | $20K | $1.5M |
| 612 | Heartflow, Inc. | $17K | $282M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Synthetic Scaffoldsgranted
- Method And Device For In Vivo Bronchus Regenerationgranted
- Methods And Compositions For Promoting The Structural Integrity Of Scaffolds For Tissue Engineeringgranted
- Systems And Methods For Producing Gastrointestinal Tissuesgranted
- Bioreactor Connectorsgranted
- Method And Device For In Vivo Tissue Regeneration On The Interior Surface Of Hollow Organsgranted
- Synthetic Scaffoldsapplication
- Synthetic Scaffoldsgranted
- Method And Device For In Vivo Bronchus Regenerationgranted
- Systems and Methods for Producing Gastrointestinal Tissuesgranted
- Bioreactors And Uses Thereofgranted
- Bioreactor Connectorsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.